research use only
Cat.No.S8792
| Related Targets | Dehydrogenase HSP Transferase P450 (e.g. CYP17) PDE phosphatase PPAR Vitamin Carbohydrate Metabolism Mitochondrial Metabolism |
|---|---|
| Other Ferroptosis Inhibitors | Liproxstatin-1 RSL3 Erastin Ferrostatin-1 (Fer-1) Imidazole Ketone Erastin (IKE) FIN56 iFSP1 SRS11-92 icFSP1 SRS16-86 |
| Cell Lines | Assay Type | Concentration | Incubation Time | Formulation | Activity Description | PMID |
|---|---|---|---|---|---|---|
| IMR32 | Function assay | 1 hr | Inhibition of erastin-induced ferroptosis in human IMR32 cells preincubated for 1 hr followed by erastin stimulation and measured after 13 hrs by sytox green-based fluorescence assay, IC50 = 0.01 μM. | 30354101 | ||
| IMR32 | Function assay | 1 hr | Inhibition of ferrous ammonium sulphate-induced ferroptosis in human IMR32 cells preincubated for 1 hr followed by erastin stimulation and measured after 13 hrs by sytox green-based fluorescence assay | 30354101 | ||
| Click to View More Cell Line Experimental Data | ||||||
|
In vitro |
DMSO
: 94 mg/mL
(199.29 mM)
Ethanol : 94 mg/mL Water : Insoluble |
|
In vivo |
|||||
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.
| Molecular Weight | 471.66 | Formula | C25H37N5O2S |
Storage (From the date of receipt) | 3 years -20°C powder |
|---|---|---|---|---|---|
| CAS No. | 2271358-64-4 | -- | Storage of Stock Solutions |
|
|
| Synonyms | N/A | Smiles | C1CCC(CC1)NC2=C(C=C(C=C2)S(=O)(=O)NCCN3CCNCC3)NCC4=CC=CC=C4 | ||
| Targets/IC50/Ki |
Ferroptosis
(IMR-32 Neuroblastoma Cells) 10 nM
|
|---|---|
| In vitro |
UAMC-3203 has an impressive t1/2 when incubated with both human and rat microsomes (t1/2 = 20.5 h and t1/2 = 16.5 h respectively) but this compound is found to be relatively less stable when incubated with murine microsomes (t1/2 = 3.46 h). |
| In vivo |
UAMC-3203 significantly lowers the plasma levels of lactate dehydrogenase (LDH) in mice. It is rapidly removed from the bloodstream and redistributed into various tissues, as can be expected for lipophilic basic compounds. Significant concentrations of this compound are found in all analyzed tissues (liver, kidney, and lungs). |
References |
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.